FDA Inspection
Novo Nordisk US Bio Production Inc.Novo Nordisk US Bio Production Inc. – FDA Inspection, Jul 25, 2023
Record Details
This FDA Inspection record concerns Novo Nordisk US Bio Production Inc., with an inspection on July 25, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7ff90033-28ae-475d-a08e-04d19cc180a1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1214482
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Novo Nordisk US Bio Production Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 9, 2025 | Not classified | New England District Office | |
| March 5, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 24, 2018 | Not classified | New England District Office |
Other documents for Novo Nordisk US Bio Production Inc.
- FDA Inspection 1292060 - 2025-12-09
- FDA Inspection 1255809 - 2025-03-05
- FDA Inspection 1064794 - 2018-08-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.